Viemed Healthcare Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	10.24	6.22	9.13	31.53	8.53	9.51	8.18
Depreciation & Amortization	21.86	15.63	11.31	9.58	6.4	3.78	2.54
Share-Based Compensation	5.85	5.2	5.15	4.88	3.89	2.7	0.83
Other Operating Activities	7.26	0.69	-3.09	-10.88	0.28	6.38	0.48
Operating Cash Flow	45.21	27.75	22.49	35.11	19.09	22.37	12.02
Operating Cash Flow Growth	62.94%	23.36%	-35.93%	83.95%	-14.67%	86.03%	-
Capital Expenditures	-23.51	-21.84	-19.15	-7.79	-12.81	-5.3	-3.57
Acquisitions	-28.59	0	0	0	0	0	0
Change in Investments	-0.02	-2.14	-0.6	-0.63	0	0	0
Investing Cash Flow	-52.11	-23.98	-19.75	-8.42	-12.81	-5.3	-3.57
Share Issuance / Repurchase	0.71	-9.43	-1.32	1.88	-1.13	-1.59	0
Debt Issued / Paid	2.12	-5.84	-4	-10.95	-2.21	-10.16	-7.69
Financing Cash Flow	2.83	-15.27	-5.32	-9.07	-3.33	-11.75	-7.69
Net Cash Flow	-4.08	-11.49	-2.57	17.63	2.94	5.32	0.76
Free Cash Flow	21.71	5.91	3.35	27.32	6.28	17.07	8.45
Free Cash Flow Growth	267.11%	76.67%	-87.75%	335.37%	-63.23%	101.95%	-
Free Cash Flow Margin	11.86%	4.26%	2.86%	20.81%	7.82%	26.48%	18.01%
Free Cash Flow Per Share	0.57	0.15	0.09	0.70	0.17	0.45	0.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).